These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3021615)

  • 21. [The regulation of B-lymphocyte activity by the Epstein-Barr virus in ankylosing spondylarthritis].
    Peĭcheva V; Kan A; Amor B
    Vutr Boles; 1990; 29(5):88-91. PubMed ID: 1964317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells.
    Wang W; Napoli JL; Ballow M
    Clin Exp Immunol; 1993 Apr; 92(1):164-8. PubMed ID: 8385583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-associated changes in Epstein-Barr virus-induced human lymphocyte autoantibody responses.
    Fong S; Tsoukas CD; Frincke LA; Lawrance SK; Holbrook TL; Vaughan JH; Carson DA
    J Immunol; 1981 Mar; 126(3):910-4. PubMed ID: 6257787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Vicia villosa-adherent CD8+ T cells in the immune response to Epstein-Barr virus.
    Kundu SK; Menezes J
    Viral Immunol; 1991; 4(1):23-32. PubMed ID: 1648359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.
    Kirchner H; Tosato G; Blaese RM; Broder S; Magrath IT
    J Immunol; 1979 Apr; 122(4):1310-3. PubMed ID: 221572
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of in vitro anti-DNA B-cell responses by cyclosporine.
    Mayus JL; Semper KF; Pisetsky DS
    Cell Immunol; 1985 Aug; 94(1):195-204. PubMed ID: 3874703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.
    Whittle HC; Brown J; Marsh K; Greenwood BM; Seidelin P; Tighe H; Wedderburn L
    Nature; 1984 Nov 29-Dec 5; 312(5993):449-50. PubMed ID: 6095104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epstein-Barr virus-induced production of IgE by human B cells.
    Martinez-Maza O; Guilbert B; David B; Avrameas S
    Clin Immunol Immunopathol; 1986 Jun; 39(3):405-13. PubMed ID: 3009065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of immunosuppressive agents on in vitro production of human immunoglobulins.
    Stevens C; Lempert N; Freed BM
    Transplantation; 1991 Jun; 51(6):1240-4. PubMed ID: 1710843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibition of T and B cell function in IL-4-dependent IgE production by cyclosporin A and methylprednisolone.
    Renz H; Mazer BD; Gelfand EW
    J Immunol; 1990 Dec; 145(11):3641-6. PubMed ID: 2246507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A.
    Crawford DH; Sweny P; Edwards JM; Janossy G; Hoffbrand AV
    Lancet; 1981 Jan; 1(8210):10-2. PubMed ID: 6109048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.
    Bende RJ; Jochems GJ; Frame TH; Klein MR; van Eijk RV; van Lier RA; Zeijlemaker WP
    Cell Immunol; 1992 Sep; 143(2):310-23. PubMed ID: 1324802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.
    Yarchoan R; Tosato G; Blaese RM; Simon RM; Nelson DL
    J Exp Med; 1983 Jan; 157(1):1-14. PubMed ID: 6294212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: a common feature of autoimmune disease.
    Shore A; Klock R; Lee P; Snow KM; Keystone EC
    J Clin Immunol; 1989 Mar; 9(2):103-10. PubMed ID: 2541162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of autoantibodies to cellular antigens by human B cells transformed by Epstein-Barr virus.
    Robinson JE; Stevens KC
    Clin Immunol Immunopathol; 1984 Dec; 33(3):339-50. PubMed ID: 6094060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.